← FDA DRUG APPROVALS

FDA ANDA · ANDA208474

LIDOCAINE HYDROCHLORIDE

Sponsor: B BRAUN MEDICAL

APPLICATION
ANDA208474
TYPE
ANDA
ORIGINAL APPROVAL
2018-08-03
LATEST ACTION
2019-10-29
ROUTE
INFILTRATION, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

LIDOCAINE HYDROCHLORIDEPrescription
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

2019-10-29Labeling · Supplement 1 · standardAP
2018-08-03UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →